These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

721 related articles for article (PubMed ID: 23580559)

  • 1. The cdr1B efflux transporter is associated with non-cyp51a-mediated itraconazole resistance in Aspergillus fumigatus.
    Fraczek MG; Bromley M; Buied A; Moore CB; Rajendran R; Rautemaa R; Ramage G; Denning DW; Bowyer P
    J Antimicrob Chemother; 2013 Jul; 68(7):1486-96. PubMed ID: 23580559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Zn2-Cys6 Transcription Factor AtrR Plays a Key Role in an Azole Resistance Mechanism of Aspergillus fumigatus by Co-regulating cyp51A and cdr1B Expressions.
    Hagiwara D; Miura D; Shimizu K; Paul S; Ohba A; Gonoi T; Watanabe A; Kamei K; Shintani T; Moye-Rowley WS; Kawamoto S; Gomi K
    PLoS Pathog; 2017 Jan; 13(1):e1006096. PubMed ID: 28052140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First determination of azole resistance in Aspergillus fumigatus strains carrying the TR34/L98H mutations in Turkey.
    Özmerdiven GE; Ak S; Ener B; Ağca H; Cilo BD; Tunca B; Akalın H
    J Infect Chemother; 2015 Aug; 21(8):581-6. PubMed ID: 26048062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High prevalence of azole resistance in Aspergillus fumigatus isolates from high-risk patients.
    Fuhren J; Voskuil WS; Boel CH; Haas PJ; Hagen F; Meis JF; Kusters JG
    J Antimicrob Chemother; 2015 Oct; 70(10):2894-8. PubMed ID: 26163402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surveillance for azole resistance in clinical and environmental isolates of Aspergillus fumigatus in Australia and cyp51A homology modelling of azole-resistant isolates.
    Talbot JJ; Subedi S; Halliday CL; Hibbs DE; Lai F; Lopez-Ruiz FJ; Harper L; Park RF; Cuddy WS; Biswas C; Cooley L; Carter D; Sorrell TC; Barrs VR; Chen SC
    J Antimicrob Chemother; 2018 Sep; 73(9):2347-2351. PubMed ID: 29846581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azole, polyene and echinocandin MIC distributions for wild-type, TR34/L98H and TR46/Y121F/T289A Aspergillus fumigatus isolates in the Netherlands.
    van Ingen J; van der Lee HA; Rijs TA; Zoll J; Leenstra T; Melchers WJ; Verweij PE
    J Antimicrob Chemother; 2015 Jan; 70(1):178-81. PubMed ID: 25301884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009.
    Bueid A; Howard SJ; Moore CB; Richardson MD; Harrison E; Bowyer P; Denning DW
    J Antimicrob Chemother; 2010 Oct; 65(10):2116-8. PubMed ID: 20729241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic perspective of triazole resistance in clinical and environmental Aspergillus fumigatus isolates without cyp51A mutations.
    Sharma C; Nelson-Sathi S; Singh A; Radhakrishna Pillai M; Chowdhary A
    Fungal Genet Biol; 2019 Nov; 132():103265. PubMed ID: 31465846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Aspergillus fumigatus multidrug transporter genes and their potential involvement in antifungal resistance.
    Meneau I; Coste AT; Sanglard D
    Med Mycol; 2016 Aug; 54(6):616-27. PubMed ID: 26933209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR/L98H mutations in the cyp51A gene in India.
    Chowdhary A; Kathuria S; Randhawa HS; Gaur SN; Klaassen CH; Meis JF
    J Antimicrob Chemother; 2012 Feb; 67(2):362-6. PubMed ID: 22028200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening and Characterization of a Non-cyp51A Mutation in an Aspergillus fumigatus cox10 Strain Conferring Azole Resistance.
    Wei X; Chen P; Gao R; Li Y; Zhang A; Liu F; Lu L
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27799210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of triazole resistance in Aspergillus fumigatus, especially mediated by TR/L98H, in a French cohort of patients with cystic fibrosis.
    Morio F; Aubin GG; Danner-Boucher I; Haloun A; Sacchetto E; Garcia-Hermoso D; Bretagne S; Miegeville M; Le Pape P
    J Antimicrob Chemother; 2012 Aug; 67(8):1870-3. PubMed ID: 22581906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vitro Activity of ASP2397 against Aspergillus Isolates with or without Acquired Azole Resistance Mechanisms.
    Arendrup MC; Jensen RH; Cuenca-Estrella M
    Antimicrob Agents Chemother; 2016 Jan; 60(1):532-6. PubMed ID: 26552973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. cyp51A-Based mechanisms of Aspergillus fumigatus azole drug resistance present in clinical samples from Germany.
    Bader O; Weig M; Reichard U; Lugert R; Kuhns M; Christner M; Held J; Peter S; Schumacher U; Buchheidt D; Tintelnot K; Groß U;
    Antimicrob Agents Chemother; 2013 Aug; 57(8):3513-7. PubMed ID: 23669382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concomitant occurrence of itraconazole-resistant and -susceptible strains of Aspergillus fumigatus in routine cultures.
    Ahmad S; Joseph L; Hagen F; Meis JF; Khan Z
    J Antimicrob Chemother; 2015 Feb; 70(2):412-5. PubMed ID: 25326091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspergillus species collected from environmental air samples in Portugal-molecular identification, antifungal susceptibility and sequencing of cyp51A gene on A. fumigatus sensu stricto itraconazole resistant.
    Monteiro C; Pinheiro D; Maia M; Faria MA; Lameiras C; Pinto E
    J Appl Microbiol; 2019 Apr; 126(4):1140-1148. PubMed ID: 30735287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of triazole resistance in clinical Aspergillus fumigatus isolates in a specialist cardiothoracic centre.
    Abdolrasouli A; Scourfield A; Rhodes J; Shah A; Elborn JS; Fisher MC; Schelenz S; Armstrong-James D
    Int J Antimicrob Agents; 2018 Nov; 52(5):637-642. PubMed ID: 30103005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative Analysis of Single-Nucleotide Polymorphism for Rapid Detection of TR34/L98H- and TR46/Y121F/T289A-Positive Aspergillus fumigatus Isolates Obtained from Patients in Iran from 2010 to 2014.
    Mohammadi F; Hashemi SJ; Zoll J; Melchers WJ; Rafati H; Dehghan P; Rezaie S; Tolooe A; Tamadon Y; van der Lee HA; Verweij PE; Seyedmousavi S
    Antimicrob Agents Chemother; 2016 Jan; 60(1):387-92. PubMed ID: 26525787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspergillus fumigatus harbouring the sole Y121F mutation shows decreased susceptibility to voriconazole but maintained susceptibility to itraconazole and posaconazole.
    Lescar J; Meyer I; Akshita K; Srinivasaraghavan K; Verma C; Palous M; Mazier D; Datry A; Fekkar A
    J Antimicrob Chemother; 2014 Dec; 69(12):3244-7. PubMed ID: 25125676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in the cyp51A gene and susceptibility to itraconazole in Aspergillus fumigatus serially isolated from a patient with lung aspergilloma.
    Chen J; Li H; Li R; Bu D; Wan Z
    J Antimicrob Chemother; 2005 Jan; 55(1):31-7. PubMed ID: 15563516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.